If you don't meet the eligibility requirements for the Medicare GLP-1 Bridge Program, you still have options
doi: 10.1126/science.1110591 6 SuauABonnetRSutrenMGodonJJGibsonGRCollinsMDet al
The body's metabolic adaptations to weight lossincluding decreased energy expenditure, increased hunger hormones, and reduced satiety signalspersist long after weight reduction, making weight maintenance challenging without continued intervention
Liraglutide and Semaglutide GLP-1 are medications that mimic the effects of a hormone called glucagon-like peptide-1 (GLP-1), aiding in the release of insulin and helping to lower blood sugar levels
Research from Yoon and colleagues, published in Nature Medicine, demonstrated that P9 binds to ICAM-2 receptors on L cells and directly stimulates GLP-1 secretion
These treatments help regulate appetite, improve metabolism, and promote healthy, sustainable weight management under personalized care